It has been nearly three years since the Fenwall deal was announced and they began seeking China approval. Already six months since the Golden Meditech deal was announced.
During the last cc in November Matt said they expected China approval before the end of the calendar year. That didn't happen. He also said they would be selling product to Golden Meditech that quarter. Given the lack of approval, I am guessing that didn't happen either. He also said that Artherex is expected to receive regulatory approval during the current quarter (ending in March), who thinks that is going to happen?